Rochester, MN, United States of America

Robert B Jenkins

This inventor holds 18 USPTO granted patents and 10 published patent applications, plus 1 CIPO patent and 6 EPO patents, primarily in Cancer Diagnostics. Top assignees: Mayo Foundation for Medical Education and Research, Abbott Molecular Inc., Vysis, Inc.. Active years: 2001-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert B Jenkins. Retrieved from https://idiyas.com/inventor/robert-b-jenkins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 18 

% Patents Active = 38.9


 

Average Co-Inventor Count = 2.6

ph-index = 6

Forward Citations = 144(Granted Patents)


Location History:

  • Hobe Sound, FL (US) (2011 - 2012)
  • Kaaawa, HI (US) (2014)
  • Rochester, MN (US) (2001 - 2021)

Company Filing History:


Years Active: 2001-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Cancer Diagnostics
Biomarkers
Machine Learning
Peptide Delivery
Prostate Cancer
Blood-Brain Barrier
Active Agents
Screw Fasteners
Thermostatic Mixing
Interactive Craft
Diagnosis Methods
Prognosis Panels
18 patents (USPTO):Explore Patents

Title: The Innovative Journey of Robert B. Jenkins: Advancements in Machine Learning and Cancer Diagnostics

Introduction: Robert B. Jenkins, an accomplished inventor based in Rochester, MN, has made significant contributions to the fields of machine learning and cancer diagnostics through his innovative inventions. With a total of 18 patents to his name, Jenkins continues to push the boundaries of technology and healthcare, improving methodologies and systems that have profound implications for patient care and treatment.

Latest Patents: Among Jenkins' latest patents is a groundbreaking system for preprocessing target data and generating predictions using a machine learning model. This invention utilizes machine learning to generate likelihood scores related to various health conditions by effectively processing target data derived from samples. The model incorporates advanced techniques, including the use of pre-computed vectors derived from training datasets, showcasing its versatility and potential in clinical applications.

Additionally, Jenkins has developed innovative methods, systems, and kits for cancer diagnostics utilizing biomarkers. This work focuses on the prognosis and evaluation of cancer progression, integrating expression-based analysis of biomarkers into diagnostic frameworks. His approaches have the potential to transform how cancer is assessed and treated, providing essential insights for clinicians.

Career Highlights: Jenkins has spent a significant portion of his career at the Mayo Foundation for Medical Education and Research, where he has honed his skills and contributed to cutting-edge research. His work is characterized by a commitment to leveraging technology for medical advancements, with a focus on practical applications that can benefit healthcare providers and patients alike.

Collaborations: Throughout his career, Jenkins has collaborated with esteemed colleagues, including Kevin C. Halling and Walter E. King. These partnerships have enriched his research endeavors, facilitating the exchange of ideas and fostering innovation within the field.

Conclusion: Robert B. Jenkins exemplifies the spirit of innovation in the realms of machine learning and cancer diagnostics. His 18 patents reflect a dedication to enhancing healthcare through technology, and his ongoing work promises to yield even greater advancements in the future. Jenkins' contributions not only advance scientific knowledge but also hold the potential to improve patient outcomes across diverse medical contexts.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…